Key result
TEVAR cuts 30-day mortality and complications vs OSR but increases mid-to-long-term re-intervention rates.
Why the study?
The long-term mortality and re-intervention rates of thoracic endovascular aortic repair compared to open surgical repair for thoracic aortic aneurysm are unclear.
Does TEVAR improve early mortality, long-term survival, and re-intervention rates compared to open surgical repair in patients with thoracic aortic aneurysm?
Comparison
Thoracic endovascular aortic repair versus open surgical repair
Design
Systematic review and meta-analysis
Loading...
TEVAR linked to higher long-term mortality than OSR for descending thoracic aneurysms; randomized trials needed to confirm.
Meta-Analysis
Does TEVAR improve early mortality, long-term survival, and re-intervention rates compared to open surgical repair in patients with thoracic aortic aneurysm?
TEVAR provides superior early clinical outcomes compared to open surgical repair for thoracic aortic aneurysms, but is associated with a higher risk of mid-to-long-term re-intervention.
A 2021 study conducted a meta-analysis in Thoracic aortic aneurysm. Thoracic endovascular aortic repair (TEVAR) vs. Open surgical repair (OSR) was evaluated on Early mortality, mid-to-long-term survival, and re-intervention. Thoracic endovascular aortic repair significantly reduced 30-day mortality and complications compared to open surgical repair, but had a higher mid-to-long-term re-intervention rate.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: